Granzyme A Is Required for Regulatory T-Cell Mediated Prevention of Gastrointestinal Graft-versus-Host Disease

被引:25
作者
Velaga, Sarvari [1 ]
Ukena, Sya N. [1 ]
Dringenberg, Ulrike [1 ]
Alter, Christina [1 ]
Pardo, Julian [2 ]
Kershaw, Olivia [3 ]
Franzke, Anke [1 ]
机构
[1] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany
[2] Biomed Res Ctr Aragon CIBA, Immune Effector Cells Grp ICE, Zaragoza, Spain
[3] Free Univ Berlin, Dept Vet Pathol, Berlin, Germany
来源
PLOS ONE | 2015年 / 10卷 / 04期
关键词
DEATH; TRANSPLANTATION; PERFORIN; SUPPRESSION; PROTECTS; PATHWAY; ROLES;
D O I
10.1371/journal.pone.0124927
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In our previous work we could identify defects in human regulatory T cells (Tregs) likely favoring the development of graft-versus-host disease (GvHD) following allogeneic stem cell transplantation (SCT). Treg transcriptome analyses comparing GvHD and immune tolerant patients uncovered regulated gene transcripts highly relevant for Treg cell function. Moreover, granzyme A (GZMA) also showed a significant lower expression at the protein level in Tregs of GvHD patients. GZMA induces cytolysis in a perforin-dependent, FAS-FASL independent manner and represents a cell-contact dependent mechanism for Tregs to control immune responses. We therefore analyzed the functional role of GZMA in a murine standard model for GvHD. For this purpose, adoptively transferred CD4(+)CD25(+) Tregs from gzmA(-/-) mice were analyzed in comparison to their wild type counterparts for their capability to prevent murine GvHD. GzmA(-/-) Tregs home efficiently to secondary lymphoid organs and do not show phenotypic alterations with respect to activation and migration properties to inflammatory sites. Whereas gzmA(-/-) Tregs are highly suppressive in vitro, Tregs require GZMA to rescue hosts from murine GvHD, especially regarding gastrointestinal target organ damage. We herewith identify GZMA as critical effector molecule of human Treg function for gastrointestinal immune response in an experimental GvHD model.
引用
收藏
页数:9
相关论文
共 24 条
[1]   Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease [J].
Anderson, BE ;
McNiff, JM ;
Matte, C ;
Athanasiadis, I ;
Shlomchik, WD ;
Shlomchik, MJ .
BLOOD, 2004, 104 (05) :1565-1573
[2]  
[Anonymous], BLOOD, DOI DOI 10.1182/BLOOD-2010-10-311894
[3]   Elucidating Sources and Roles of Granzymes A and B during Bacterial Infection and Sepsis [J].
Arias, Maykel A. ;
Jimenez de Baguees, Maria P. ;
Aguilo, Nacho ;
Menao, Sebastian ;
Hervas-Stubbs, Sandra ;
de Martino, Alba ;
Alcaraz, Ana ;
Simon, Markus M. ;
Froelich, Christopher J. ;
Pardo, Julian .
CELL REPORTS, 2014, 8 (02) :419-428
[4]   Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway [J].
Bird, CH ;
Sutton, VR ;
Sun, JR ;
Hirst, CE ;
Novak, A ;
Kumar, S ;
Trapani, JA ;
Bird, PI .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (11) :6387-6398
[5]   Granzyme B is not required for regulatory T cell-mediated suppression of graft-versus-host disease [J].
Cai, Sheng F. ;
Cao, Xuefang ;
Hassan, Anjum ;
Fehniger, Todd A. ;
Ley, Timothy J. .
BLOOD, 2010, 115 (09) :1669-1677
[6]   Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance [J].
Cao, Xuefang ;
Cai, Sheng F. ;
Fehniger, Todd A. ;
Song, Jiling ;
Collins, Lynne I. ;
Piwnica-Worms, David R. ;
Ley, Timothy J. .
IMMUNITY, 2007, 27 (04) :635-646
[7]   CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease [J].
Cohen, JL ;
Trenado, A ;
Vasey, D ;
Klatzmann, D ;
Salomon, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :401-406
[8]   An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation .1. The roles of minor H antigens and endotoxin [J].
Cooke, KR ;
Kobzik, L ;
Martin, TR ;
Brewer, J ;
Delmonte, J ;
Crawford, JM ;
Ferrara, JLM .
BLOOD, 1996, 88 (08) :3230-3239
[9]   CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation [J].
Edinger, M ;
Hoffmann, P ;
Ermann, J ;
Drago, K ;
Fathman, CG ;
Strober, S ;
Negrin, RS .
NATURE MEDICINE, 2003, 9 (09) :1144-1150
[10]   Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD [J].
Ermann, J ;
Hoffmann, P ;
Edinger, M ;
Dutt, S ;
Blankenberg, FG ;
Higgins, JP ;
Negrin, RS ;
Fathman, CG ;
Strober, S .
BLOOD, 2005, 105 (05) :2220-2226